Page 365 - Medicine and Surgery
P. 365

P1: KTX
         BLUK007-08  BLUK007-Kendall  May 12, 2005  19:48  Char Count= 0








                                                                           Chapter 8: Seropositive arthritis 361




                         Heart:                                             Eyes:
                         Cardiac involvement includes                       Sjogren's syndrome causes dry gritty
                         pericarditis (10% clinically evident).             eyes.
                         Myocarditis does occur but is rare.                Scleritis and episcleritis present as an
                                                                            acute, red painful eye.
                                                                            Degradation of scleral collagen (blue
                         Lung:                                              appearance) which rarely may
                         Pleural involvement is common and                  progress to perforation (scleromalacia
                         may result in pain and effusions.                  perforans)
                         Interstitial fibrosis, lung nodules and
                         small airway disease may all occur.
                         Patients with co-existent
                         pneumoconiosis may produce large                   Kidney:
                         cavitating lung nodules (Caplan's                  Direct renal damage is rare however
                         syndrome). Bronchiolitis obliterans                most of the drugs used in the treatment
                         with organizing pneumonia (BOOP)                   of rheumatoid arthritis can cause renal
                         is rare.                                           disease.





                         Skin:                                              Haematology:
                         Rheumatoid nodules are found in 20%                Splenomegaly and neutropenia in
                         of patients. They consist of a central             rheumatoid arthritis is termed Felty's
                         necrotic core surrounded by a layer of             syndrome. Anaemia may occur due to
                         fibroblasts with an outer coat of                  chronic disease iron deficiency, or
                         lymphocytes. Nodules commonly                      rarely haemolysis.
                         occur at pressure points but may form
                         on any internal or external surface.
                         Raynaud's phenomenon is common.





                  Figure 8.1 Extra-articular features of rheumatoid arthritis.



                    but because of side effects, doses should be gradually     Tumour necrosis factor alpha (TNF-α) inhibitors
                    reduced and stopped if possible once the disease is  (etanercept and infliximab) are used in patients with
                    quiescent.                                   persistently active rheumatoid arthritis that has not
                    Disease modifying antirheumatic drugs: Patients with  responded adequately to at least two DMARDs, in-

                    rheumatoid arthritis should be treated with DMARDs  cluding methotrexate.
                    soon after diagnosis, as these have been shown to im-     Anti-cytokines including anti-IL-1 and anti-IL-6 are
                    proveprognosis.Theyacttoamelioratesymptomsand  undergoing evaluation.
                    slow progression of structural damage. Methotrex-     Because of immobility and steroid therapy patients
                    ate is normally used as first line, other agents include  with rheumatoid arthritis are at high risk for develop-
                    sulphasalazine, gold and hydroxychloroquine. Com-  ment of osteoporosis. Most patients should be treated
                    binations of DMARDs are increasingly used. Onset  with calcium and vitamin D supplementation. Bis-
                    is slow, 10–20 weeks, and all have some degree of  phosphonate therapy should be considered in high-
                    toxicity.                                    risk patients.
   360   361   362   363   364   365   366   367   368   369   370